» Authors » Mathieu Luyckx

Mathieu Luyckx

Explore the profile of Mathieu Luyckx including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 214
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Manzour N, Chiva L, Zanagnolo V, Capilna M, Bizzarri N, Mom C, et al.
Int J Gynecol Cancer . 2025 Mar; :101690. PMID: 40055121
Objective: Interest in long-term outcomes of radical hysterectomy for cervical cancer has increased, especially after the LACC trial findings, which showed worse outcomes for minimally invasive surgery. However, limited information...
2.
Herbin C, Jadoul P, Hosten E, Gerday A, Luyckx M, Squifflet J, et al.
J Med Case Rep . 2024 Aug; 18(1):393. PMID: 39182131
Background: Cervicitis, an infectious or noninfectious inflammation of the cervix, encompasses a wide range of clinical conditions, from asymptomatic infections to severe lesions, making its diagnosis difficult. Acute cervicitis may...
3.
Hirsch T, Neyens D, Duhamel C, Bayard A, Vanhaver C, Luyckx M, et al.
Cell Rep . 2024 Jun; 43(7):114401. PMID: 38943641
Human CD8 tumor-infiltrating lymphocytes (TILs) with impaired effector functions and PD-1 expression are categorized as exhausted. However, the exhaustion-like features reported in TILs might stem from their activation rather than...
4.
Luyckx M, Verougstraete C, Jouret M, Sawadogo K, Waterkeyn M, Grandjean F, et al.
J Clin Med . 2024 Mar; 13(6). PMID: 38541772
Introduction: Surgery is the cornerstone of ovarian cancer treatment. However, surgery and perioperative inflammation have been described as potentially pro-metastagenic. In various animal models and other human cancers, intraoperative administration...
5.
Bourgeois J, Peacock H, Savoye I, De Gendt C, Leroy R, Silversmit G, et al.
Eur J Surg Oncol . 2024 Feb; 50(3):107978. PMID: 38306864
Background: Different sets of quality indicators are used to identify areas for improvement in ovarian cancer care. This study reports transparently on how (surgical) indicators were measured and on the...
6.
Neyens D, Hirsch T, Abdel Aziz Issa Abdel Hadi A, Dauguet N, Vanhaver C, Bayard A, et al.
Front Immunol . 2024 Jan; 14:1308539. PMID: 38187391
Introduction: The transcription factor HELIOS is primarily known for its expression in CD4 regulatory T cells, both in humans and mice. In mice, HELIOS is found in exhausted CD8 T...
7.
Vanhaver C, Aboubakar Nana F, Delhez N, Luyckx M, Hirsch T, Bayard A, et al.
Life Sci Alliance . 2023 Nov; 7(1). PMID: 37931958
The presence of human neutrophils in the tumor microenvironment is strongly correlated to poor overall survival. Most previous studies have focused on the immunosuppressive capacities of low-density neutrophils (LDN), also...
8.
Savoye I, Silversmit G, Bourgeois J, De Gendt C, Leroy R, Peacock H, et al.
Eur J Cancer . 2023 Nov; 195:113402. PMID: 37922631
Objectives: To study the association between hospital volume and outcomes in patients with invasive epithelial ovarian cancer (EOC). Methods: This study included 3988 patients diagnosed with invasive EOC between 2014...
9.
Luyckx M, Jouret M, Sawadogo K, Waterkeyn M, Grandjean F, Van Gossum J, et al.
Int J Gynecol Cancer . 2023 Oct; 34(1):106-112. PMID: 37844964
Objective: In Belgium there is no centralization of surgery for ovarian cancer, with more than 100 centers treating around 800 cases per year. In 2017 a network with several collaborating...
10.
de Codt M, Jadoul P, Luyckx M, Squifflet J, Dolmans M, Maillard C, et al.
Rare Tumors . 2023 Apr; 15:20363613231168767. PMID: 37035475
Hydatidiform Mole (HM) is the most common form of gestational trophoblastic disease. Dilatation and curettage is the classical treatment of this affection. Hysteroscopic resection (HsR) is an alternative for the...